First Tracks Biotherapeutics, Inc. (TRAX)

39.09 +0.62 (+1.61%) USD  |  NASDAQ  |  Sep 16, 15:33
More

First Tracks Biotherapeutics Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for TRAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Return on Net Operating Assets Data

View and export this data back to . Start Trial.
Date Value

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Forte Biosciences, Inc. Upgrade
Immunovant, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Agenus, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade